The Hospital Universitario La Paz, HULP, is a general tertiary hospital situated in the neighbourhood that takes its name from the hospital in the northern city district of Fuencarral-El Pardo in the city of Madrid in Spain.

There are 1,308 beds in Hospital Universitario La Paz.

During the past decade, Hospital Universitario La Paz conducted 777 clinical trials. In the 10-year time frame, 777 clinical trials started and 250 clinical trials were completed, i.e. on average, 32.2% percent of trials that started reached the finish line to date. In the past 5 years, 395 clinical trials started and 173 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario La Paz" #1 sponsor was "Instituto de Investigación Hospital Universitario La Paz" with 58 trials, followed by "Pfizer" with 51 trials sponsored, "Janssen Research & Development, LLC" with 37 trials sponsored, "Gilead Sciences" with 33 trials sponsored and "Hoffmann-La Roche" with 33 trials sponsored. Other sponsors include 882 different institutions and companies that sponsored additional 412 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario La Paz" #1 collaborator was "Hospital Universitario La Paz" with 22 trials as a collaborator, "Merck Sharp & Dohme LLC" with 16 trials as a collaborator, "Hoffmann-La Roche" with 12 trials as a collaborator, "AstraZeneca" with 10 trials as a collaborator and "Bristol-Myers Squibb" with 10 trials as a collaborator. Other collaborators include 596 different institutions and companies that were collaborators in the rest 405 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario La Paz" are "HIV Infections" (34 trials), "Breast Cancer" (19 trials), "Coronary Artery Disease" (17 trials), "Ulcerative Colitis" (17 trials) and "COVID-19" (15 trials). Many other conditions were trialed in "Hospital Universitario La Paz" in a lesser frequency.

Most popular intervention types in "Hospital Universitario La Paz" are "Drug" (765 trials), "Other" (102 trials), "Biological" (85 trials), "Device" (79 trials) and "Procedure" (53 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (176 trials), "Carboplatin" (20 trials), "Paclitaxel" (18 trials), "Pembrolizumab" (18 trials) and "Cisplatin" (15 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario La Paz" are 994 trials for "All" genders, 66 trials for "Female" genders and 35 trials for "Male" genders.

Currently, there are 394 active trials in "Hospital Universitario La Paz". 4 are not yet recruiting, 248 are recruiting, 140 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 523 completed trials in Hospital Universitario La Paz, 2 suspended trials, and 100 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario La Paz, 87 "Phase 1" clinical trials were conducted, 308 "Phase 2" clinical trials and 400 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 104 trials, and there were also 94 trials that are defined as “Not Applicable".

Hospital Universitario La Paz has several departments that took part in Clinical trials: "Hospital Universitario La Paz - Paediatric Cardiology Department - Site 1906" - 2 trials